| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/12/2013 | CN103142488A GLP-I analogue liraglutide sustained-release microspheres and preparation method thereof |
| 06/12/2013 | CN103142486A Calcitriol powder and preparation method thereof |
| 06/12/2013 | CN103142484A Fenofibrate lipid cubic liquid crystal solid powder and preparation method thereof |
| 06/12/2013 | CN103142483A Dry suspension of mannose ester, and its preparation method |
| 06/12/2013 | CN103142478A Calcitriol emulsion and preparation method thereof |
| 06/12/2013 | CN103142476A Calcitriol suspension and preparation method thereof |
| 06/12/2013 | CN103142475A Exenatideacetate sustained-release microsphere preparation and preparation method thereof |
| 06/12/2013 | CN103142471A Calcitriol solution and preparation method thereof |
| 06/12/2013 | CN103142470A Calcitriol injection and preparation method thereof |
| 06/12/2013 | CN103142467A Calcitriol ointment and preparation method thereof |
| 06/12/2013 | CN103142466A Calcitriol gel and preparation method thereof |
| 06/12/2013 | CN103141892A Cucumber seed beverage and preparation method and application thereof |
| 06/12/2013 | CN103141853A Theaflavin health-care food or medicament and preparation method thereof |
| 06/12/2013 | CN103141829A Preparation method for concentrated dandelion juice |
| 06/12/2013 | CN102671137B Medicine composition for treating diabetic nephropathy and preparation method of medicine composition |
| 06/12/2013 | CN102600228B Method for preparing gypenoside in gypenoside grains |
| 06/12/2013 | CN102512561B Traditional Chinese medicine spleen-tonifying and blood lipid-lowering decoction for treating spleen deficiency phlegm accumulation-type hyperlipemia |
| 06/12/2013 | CN102512388B Glimepiride orally disintegrating medicine composition |
| 06/12/2013 | CN102499905B Controllable photoresponse type hydrophobic medicament carrier hydrogel and preparation method thereof |
| 06/12/2013 | CN102488815B Buccal tablet for reducing blood sugar |
| 06/12/2013 | CN102451188B High-energy nutrient infusion solution and preparation method thereof |
| 06/12/2013 | CN102451187B High-energy nutrient infusion solution and preparation method thereof |
| 06/12/2013 | CN102441156B Traditional Tibetan medicinal composition and preparation method thereof |
| 06/12/2013 | CN102430001B Compound rose-hip flavone preparation for preventing diabetes mellitus and preparation method thereof |
| 06/12/2013 | CN102379843B Levocarnitine pharmaceutical composition for injection |
| 06/12/2013 | CN102362863B Orlistat-containing preparation and preparation method thereof |
| 06/12/2013 | CN102357156B Healthcare product with lead-removing function |
| 06/12/2013 | CN102343026B Traditional Chinese medicine composition for treating diabetes and preparation method thereof |
| 06/12/2013 | CN102329520B Method for preparing lutein nanometer liquid |
| 06/12/2013 | CN102309632B Application of pharmaceutical composition in preparation of pharmaceuticals for treating complications of diabetes |
| 06/12/2013 | CN102170798B Composition for promoting control of total and LDL cholesterol and/or weight loss and/or thermogenesis |
| 06/12/2013 | CN102153641B Preparation method and application of mutain of human insulin-like growth factor binding protein 7 (IGFBP7) |
| 06/12/2013 | CN102134226B Phenyl C-glucoside derivatives, preparation method and use thereof |
| 06/12/2013 | CN102133402B Application of cystic fibrosis transmembrane transduction regulating factor inhibitor to preparation of medicaments for treating diabetes |
| 06/12/2013 | CN102113996B Oral formulations containing protein or peptide, and preparation method and application thereof |
| 06/12/2013 | CN101985644B Momordica charantia polypeptide, preparation method and application thereof |
| 06/12/2013 | CN101983072B Mineral absorption accelerator and iron deficiency anemia improver or food composition |
| 06/12/2013 | CN101959515B Glucokinase activators |
| 06/12/2013 | CN101932562B Carbamoyl compounds as dgat1 inhibitors 190 |
| 06/12/2013 | CN101906054B N-(3,4-dyhydroxy benzoyl)-3,4-dyhydroxy benzamide and preparation method and application thereof |
| 06/12/2013 | CN101835480B Ligand agent for peroxisome proliferator-activated receptor (PPAR) |
| 06/12/2013 | CN101801370B Composition comprising sesamin component and arachidonic acid component |
| 06/12/2013 | CN101780140B Drug for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
| 06/12/2013 | CN101684106B Thiazole onium salt compound and application for treating diseases relative to protein aging thereof |
| 06/12/2013 | CN101652081B Liquid nutritional composition containing sodium at high concentration and method of producing the same |
| 06/12/2013 | CN101594861B Modulation of prostaglandin/cyclooxygenase metabolic pathways |
| 06/12/2013 | CN101490015B 瑞舒伐他汀锌盐 Rosuvastatin zinc |
| 06/12/2013 | CN101472577B Infusion preparation for dialysis patient |
| 06/12/2013 | CN101352433B Formulation capable of effectively balancing blood pressure, blood fat and promoting cardio-cerebral arterial vascular softening, and preparation method thereof |
| 06/12/2013 | CN101190248B Long chain fatty milk in camelina sativa oil orally-administered or injection preparations |
| 06/12/2013 | CN101094689B Treatment of obesity and related disorders |
| 06/12/2013 | CN101018546B (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 06/11/2013 | US8461331 Method for the production of 3,6-dihydro-L, 3, 5-triazine derivatives from metformin and paraldehyde derivatives |
| 06/11/2013 | US8461212 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 06/11/2013 | CA2730511C 4-phenoxymethylpiperidines as modulators of gpr119 activity |
| 06/11/2013 | CA2649706C Cell therapy: a method and a composition for treating diabetes |
| 06/11/2013 | CA2601427C A method and composition for nutritionally improving glucose control and insulin action |
| 06/11/2013 | CA2567795C Methods of treating type i diabetes by blocking vegf-mediated activity |
| 06/11/2013 | CA2448835C Use of follistatin to increase muscle mass |
| 06/11/2013 | CA2427334C Methods and compositions for the treatment of diseases of the eye |
| 06/11/2013 | CA2406839C G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 06/11/2013 | CA2404313C Human pancreatic epithelial progenitor cells and methods of isolation and use thereof |
| 06/06/2013 | WO2013082345A1 Aryl dihydropyridinone and piperidinone as mgat2 inhibitors |
| 06/06/2013 | WO2013082253A2 Non-hormonal steroid modulators of nf-kb for treatment of disease |
| 06/06/2013 | WO2013082106A1 Differentiation into brown adipocytes |
| 06/06/2013 | WO2013081118A1 Compound having read-through activity |
| 06/06/2013 | WO2013081087A1 Method for preparing optically active compound |
| 06/06/2013 | WO2013080999A1 Agent for inhibiting expression of npc1l1 and/or lipg mrna and agent for preventing and/or treating obesity |
| 06/06/2013 | WO2013080028A1 Composition based on ubidecarenone |
| 06/06/2013 | WO2013079691A1 Insulin glargine versus metformin for the first-line treatment of early type 2 diabetes |
| 06/06/2013 | WO2013079668A1 Piperidine derivatives, pharmaceutical compositions and uses thereof |
| 06/06/2013 | WO2013079501A1 Crystalline dapagliflozin hydrate |
| 06/06/2013 | WO2013079205A1 Low dose therapeutic use of glyceryl tri-(4-phenylbutyrate) |
| 06/06/2013 | WO2013078983A1 Sodium Piperonyl Pentadienoate and Use of the Same for Lowering Blood Lipid |
| 06/06/2013 | WO2013078765A1 Thienyl [3, 2-d] pyrimidin-4-one compounds, preparation method, pharmaceutical compositions and use thereof |
| 06/06/2013 | WO2013078658A1 Morus berries and avoiding glucose peaks |
| 06/06/2013 | WO2013014654A4 Formulas comprising highly soluble elements and vitamin for the prevention and amelioration of osteoporosis |
| 06/06/2013 | WO2012083185A8 Peptide-based in vivo sirna delivery system |
| 06/06/2013 | US20130144056 Human Adam-10 Inhibitors |
| 06/06/2013 | US20130143919 Pharmaceutical compositions and administrations thereof |
| 06/06/2013 | US20130143845 Vitamin d compounds and methods for enhancing muscle strength, and prevention and treatment of disease in human beings |
| 06/06/2013 | US20130143801 Methods and compositions for delivering peptides |
| 06/06/2013 | US20130143281 Chimeric PUFA Polyketide Synthase Systems and Uses Thereof |
| 06/06/2013 | US20130142794 Methods and Compositions for Increasing Arylsulfatase A Activity in the CNS |
| 06/06/2013 | CA2857689A1 Aryl dihydropyridinones and piperidinones as mgat2 inhibitors |
| 06/06/2013 | CA2857592A1 Composition based on ubidecarenone |
| 06/06/2013 | CA2857567A1 Targeted lysosomal enzyme compounds |
| 06/06/2013 | CA2857548A1 Targeted enzyme compounds and uses thereof |
| 06/06/2013 | CA2857537A1 Thienyl[3,2-d]pyrimidin-4-one compounds, preparation method, pharmaceutical compositions and use thereof |
| 06/06/2013 | CA2856967A1 Therapeutic agents comprising insulin amino acid sequences |
| 06/06/2013 | CA2855756A1 Non-hormonal steroid modulators of nf-kb for treatment of disease |
| 06/06/2013 | CA2797350A1 Co-crystal intermediates of rosuvastatin and methods of using same |
| 06/05/2013 | EP2599771A1 Naphthalene derivative |
| 06/05/2013 | EP2599482A1 Low dose therapeutic use of glyceryl tri-(4-phenylbutyrate) |
| 06/05/2013 | EP2599481A1 4-phenylbutyric acid for the treatment or prevention of various diseases |
| 06/05/2013 | EP2598517A1 Modulators of protease activated receptors |
| 06/05/2013 | EP2598483A1 Ampk-activating heterocyclic compounds and methods for using the same |
| 06/05/2013 | EP2598152A1 Treatment of metabolic syndrome and insulin resistance with citrus flavanones |
| 06/05/2013 | EP2598142A1 Diphenyl ether compounds for the treatment of liver, lung disorders, diabetic complications and cardiovascular diseases |
| 06/05/2013 | EP2598125A2 Novel methods for preventing or treating diabetes |